Dog /

Breed profile · FDA CVM July 2026 extract

Irish Wolfhound adverse-event record

Adverse-event filings for Irish Wolfhound (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#170 of 510
by report volume (all breeds)
290
FDA CVM reports on file
6.9%
death-coded share of reports
#90 of 275
by death-coded share (≥50 reports)

How the 290 reports break down

By recorded gender -- every report on file for Irish Wolfhound, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 27 20.25 13.5 6.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Irish Wolfhound drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Irish Wolfhound ranks #170 of 510 by total reports (290) and #90 of 275 by death-coded share (6.9%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#170
This breed, reports of 510
#90
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Irish Wolfhound has 290 reports now versus 285 in that prior snapshot: 5 more (1.8%).

Report change
+5
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Irish Wolfhound changes

Total Reports

290

Above-median volume

Deaths Reported

20

of 290 reports

Death-coded share of reports

6.9%

Above-median death-coded share

Avg Age at Report

4.0 yr

49.0 kg avg weight

Breed Safety Scorecard

F (31/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
6.9%

Share of reports coded as a fatality

Euthanasia rate F
3.8%

Share of reports resulting in euthanasia

Full recovery rate C+
31.7%

Share of reports coded "Recovered/Normal"

5-year trend F
+44%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Irish Wolfhound death-coded reports 6.9%
Cross-breed median

6.9% of 290 irish wolfhound reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Irish Wolfhound's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

7% 67th percentile Higher share than 67% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Irish Wolfhound 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 49.0 kg (108.0 lbs)

Top Reported Reactions

Vomiting 59
Diarrhoea 33
Emesis 28
Lethargy (see also Central nervous system depression in 'Neurological') 19
Lack of efficacy (endoparasite) - heartworm 16
Lack of efficacy - NOS 14
Lack of efficacy (endoparasite) - hookworm 13
Lack of efficacy (ectoparasite) - flea 12

Most Referenced Drugs

Milbemycin Oxime + Spinosad 67
Ivermectin + Pyrantel As Pamoate Salt 36
Pyrantel Pamoate;Sarolaner 28
Afoxolaner 22
Moxidectin 20
Spinosad 18
Bedinvetmab 16
Milbemycin Oxime + Praziquantel 13

Outcome Breakdown

Recovered/Normal
92 (33.7%)
Ongoing
86 (31.5%)
Outcome Unknown
70 (25.6%)
Euthanized
11 (4.0%)
Died
9 (3.3%)
Recovered with Sequela
5 (1.8%)

Gender Distribution

Male 166 (57.2%)
Female 119 (41.0%)
Unknown 4 (1.4%)
Mixed 1 (0.3%)

Reports by Year

Year Reports Trend
2010 11
2011 10
2012 13
2013 26
2014 19
2015 23
2016 18
2017 21
2018 18
2019 19
2020 10
2021 18
2022 9
2023 18
2024 27
2025 26
2026 4

Irish Wolfhound: high death-coded share in the FDA CVM extract

Signature read: Irish Wolfhound's 6.9% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Irish Wolfhound sits at #170 of 510 by report volume among all breeds and #137 of 298 among dog breeds, with 290 reports and 20 (6.9%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #90 of 275. Mean age at report: 4.0 years, average weight 49.0 kg (108.0 lbs).

Top reported signs: Vomiting (59), Diarrhoea (33), Emesis (28). Most-referenced drug: Milbemycin Oxime + Spinosad (67 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (36) and Pyrantel Pamoate;Sarolaner (28).

Outcome coding on 273 status-recorded reports is dominated by Recovered/Normal (33.7%). Annual submissions ranged 4-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Irish Wolfhound drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (6.9% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (49.0 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Irish Wolfhound?
There are 290 adverse event reports involving Irish Wolfhound in the FDA database, of which 20 were death-coded (6.9% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Irish Wolfhound ranks #170 of 510 by report volume among all breeds PlainBreed indexes (#137 of 298 among dog breeds).
Where does Irish Wolfhound sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Irish Wolfhound is #170 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #137 of 298. Among breeds with at least 50 reports, its death-coded share ranks #90 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Irish Wolfhound?
The most commonly reported adverse reactions for Irish Wolfhound are Vomiting (59 reports), Diarrhoea (33 reports), Emesis (28 reports), Lethargy (see also Central nervous system depression in 'Neurological') (19 reports), Lack of efficacy (endoparasite) - heartworm (16 reports).
What drugs are most frequently associated with Irish Wolfhound adverse events?
The drugs most frequently referenced in Irish Wolfhound adverse event reports are Milbemycin Oxime + Spinosad (67 reports), Ivermectin + Pyrantel As Pamoate Salt (36 reports), Pyrantel Pamoate;Sarolaner (28 reports), Afoxolaner (22 reports), Moxidectin (20 reports).
What is the average age of Irish Wolfhound in adverse event reports?
The average age of Irish Wolfhound at the time of adverse event reports is 4.0 years, with an average weight of 49.0 kg (108.0 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Irish Wolfhound (Dog), extract as of July 2026 extract. 290 reports · 20 death-coded (6.9% of reports, not a mortality rate) · #170 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →